Juvenile Idiopathic Arthritis

Posted 1 year ago by Wales Gene Park

Brief Summary The reason for this study is to see if the study drug baricitinib is safe and effective in the treatment of JIA in participants ages 1 to 17. This study is for participants that have been enrolled in studies I4V-MC-JAHV (NCT03773978) or I4V-MC-JAHU.

 Juvenile Idiopathic Arthritis /  Bristol

Posted 1 year ago by Wales Gene Park

Brief Summary This observational study aims to develop and validate quantitative magnetic resonance imaging biomarkers as measures of disease activity in juvenile idiopathic arthritis (JIA). This includes patients with enthesitis-related arthritis (ERA).

 Juvenile Idiopathic Arthritis /  London


No post found